Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 23, Issue 7, Pages 579-591
Publisher
Informa UK Limited
Online
2019-06-03
DOI
10.1080/14728222.2019.1624721
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transforming growth factor β (TGFβ) and related molecules in chronic kidney disease (CKD)
- (2019) Pacific Huynh et al. CLINICAL SCIENCE
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Levels of Connective Tissue Growth Factor (CTGF) Predict Development of Kidney Dysfunction in Type 2 Diabetes-The VADT Study
- (2018) KELLY J. HUNT et al. DIABETES
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
- (2018) Katherine R Tuttle et al. Lancet Diabetes & Endocrinology
- ASK1 contributes to fibrosis and dysfunction in models of kidney disease
- (2018) John T. Liles et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy
- (2018) Zhonglin Chai et al. DIABETES
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition
- (2018) Sandor Koszegi et al. JOURNAL OF PHYSIOLOGY-LONDON
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
- (2018) Marcel H A Muskiet et al. Lancet Diabetes & Endocrinology
- MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications
- (2017) Romano Regazzi EXPERT OPINION ON THERAPEUTIC TARGETS
- Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease
- (2017) Syamantak Majumder et al. JOURNAL OF CLINICAL INVESTIGATION
- Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice
- (2017) Hongyu Zhang et al. KIDNEY INTERNATIONAL
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation and its role in the pathogenesis of diabetes
- (2017) Amita Bansal et al. PEDIATRIC DIABETES
- The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
- (2017) David Cherney et al. PLoS One
- Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA Integrity
- (2017) Kaytee L. Pokrzywinski et al. PLoS One
- Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy
- (2017) Shan-Shan Huang et al. Scientific Reports
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
- (2016) Hiddo J.L. Heerspink et al. CIRCULATION
- Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
- (2016) Margien G.S. Boels et al. DIABETES
- Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS
- (2016) Jan H. Cornel et al. DIABETES CARE
- Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
- (2016) Ofri Mosenzon et al. DIABETES CARE
- Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
- (2016) Lennart Tonneijck et al. DIABETES CARE
- Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial
- (2016) J. Skov et al. DIABETES OBESITY & METABOLISM
- Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials
- (2016) Katherine R. Tuttle et al. DIABETES OBESITY & METABOLISM
- Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
- (2016) Lennart Tonneijck et al. DIABETOLOGIA
- JAK inhibition in the treatment of diabetic kidney disease
- (2016) Frank C. Brosius et al. DIABETOLOGIA
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Stromal cell–derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
- (2016) Satoru Takashima et al. KIDNEY INTERNATIONAL
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes
- (2016) Muralikrishna Gangadharan Komala et al. NEPHROLOGY
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes
- (2015) Mark E. Cooper et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- ASK1 Inhibitor Halts Progression of Diabetic Nephropathy inNos3-Deficient Mice
- (2015) Greg H. Tesch et al. DIABETES
- Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor
- (2015) Pablo Lapuerta et al. Diabetes & Vascular Disease Research
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Insights Into Molecular Mechanisms of Diabetic Kidney Disease
- (2014) Shawn S. Badal et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
- (2014) Melanie P. Chin et al. JOURNAL OF CARDIAC FAILURE
- Autophagy in diabetic nephropathy
- (2014) Yan Ding et al. JOURNAL OF ENDOCRINOLOGY
- Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
- (2014) J. C. Jha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease
- (2014) D. Galasko et al. NEUROLOGY
- Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
- (2014) Naoto Terami et al. PLoS One
- Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial
- (2014) Katsuyuki Ando et al. Lancet Diabetes & Endocrinology
- US Renal Data System 2013 Annual Data Report
- (2013) Allan J. Collins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
- (2013) Despoina Vasilakou et al. ANNALS OF INTERNAL MEDICINE
- Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
- (2013) Yuji Ishibashi et al. Cardiovascular Diabetology
- NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
- (2013) Stephen P. Gray et al. CIRCULATION
- microRNA in the development of diabetic complications
- (2013) Aaron D. McClelland et al. CLINICAL SCIENCE
- Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
- (2013) P.-H. Groop et al. DIABETES CARE
- Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
- (2013) J.-F. Yale et al. DIABETES OBESITY & METABOLISM
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men
- (2013) Jeppe Skov et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Why Do SGLT2 Inhibitors Inhibit Only 30-50% of Renal Glucose Reabsorption in Humans?
- (2012) J. Liu et al. DIABETES
- Sitagliptin Exerts an Antinflammatory Action
- (2012) Antoine Makdissi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
- (2012) Markus L. Alter et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat
- (2012) Richard E. Gilbert et al. PLoS One
- MicroRNAs and Diabetic Complications
- (2012) Rama Natarajan et al. Journal of Cardiovascular Translational Research
- Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
- (2011) Edmund J. Lewis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes
- (2011) Karly C. Sourris et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pyridoxamine, Advanced Glycation Inhibition, and Diabetic Nephropathy
- (2011) J. L. T. Chen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Epigenetics in Diabetic Kidney Disease
- (2011) M. A. Reddy et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
- (2011) D. E. Kohan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pirfenidone for Diabetic Nephropathy
- (2011) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
- (2011) Peter Kolkhof et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Prevention of diabetic nephropathy in Ins2+/−AkitaJmice by the mitochondria-targeted therapy MitoQ
- (2010) Balu K. Chacko et al. BIOCHEMICAL JOURNAL
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling Loop
- (2010) Michael S. Simonson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic Histone Methylation Modulates Fibrotic Gene Expression
- (2010) G. Sun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hepatocyte growth factor has a role in the amelioration of diabetic vascular complications via autophagic clearance of advanced glycation end products: Dispo85E, an HGF inducer, as a potential botanical drug
- (2010) Kang-Yung Peng et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Termination of autophagy and reformation of lysosomes regulated by mTOR
- (2010) Li Yu et al. NATURE
- The RAAS in the pathogenesis and treatment of diabetic nephropathy
- (2010) Piero Ruggenenti et al. Nature Reviews Nephrology
- Dose-Dependent Acute and Sustained Renal Effects of the Endothelin Receptor Antagonist Avosentan in Healthy Subjects
- (2009) J Smolander et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Should All Diabetic Patients Be Treated With a Statin?
- (2009) Y. Kamari et al. DIABETES CARE
- Pirfenidone Is Renoprotective in Diabetic Kidney Disease
- (2009) S. P. RamachandraRao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
- (2009) W. Lieberthal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study
- (2008) N. Rabbani et al. DIABETOLOGIA
- Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
- (2008) Assam El-Osta et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now